A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Nicholas Spetsieris, Myrto Boukovala, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana Aparicio, Shi Ming Tu, John C. Araujo, Amado J. Zurita, Paul G. Corn, Lance Pagliaro, Jeri Kim, Jennifer Wang, Sumit K. Subudhi, Nizar M. Tannir, Christopher J. Logothetis, Patricia Troncoso, Xuemei Wang, Sijin Wen, Eleni Efstathiou

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences